Figure 9
From: L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease
Effect of CDCArg on serum hepatic enzyme levels, liver weight and liver histology. Treatments: Mice were fed with LFD for 14 weeks or with HFD for 10 weeks. At week 10 the HFD group was divided randomly into two equal groups that were pair fed. One group received HFD, while the other group received HFD + CDCArg. (A-C) Average serum SGPT, SGOT or Alkaline Phosphatase levels. (D) Liver weight. (E) Representative liver histologic sections stained with H&E (Magnification 200X).